Intraductal spread of pancreatic cancer - Clinicopathologic study of 54 pancreatectomized patients

被引:38
作者
Yamasaki, S [1 ]
Suda, K [1 ]
Nobukawa, B [1 ]
Sonoue, H [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Pathol 1, Bunkyo Ku, Tokyo 1138421, Japan
关键词
pancreas; ductal adenocarcinoma; intraductal spread; intraductal carcinoma; carcinoma in situ; Ki67;
D O I
10.1159/000065089
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Invasive ductal adenocarcinoma of the pancreas (IDAP) also spreads through the pancreatic ductal tree. The aim of this study was to clarify the clinicopathologic features of IDAP with intraductal spread. Methods: We studied the intraductal spread of IDAP and its correlation with clinicopathologic parameters in a surgical series of 54 patients. The pancreatic ducts were analyzed by confirmation of mural elastic fibers with elastica van Gieson stain. Results: Intraductal spread of carcinoma was identified in 37 patients (69%). Such spread was frequent in well-differentiated IDAP (93%), and the number of intraductal carcinoma foci was correlated with the grade of tumor differentiation (p < 0.001). The large branch ducts were the main route of intraductal spread (64.1%). The proliferation index, evaluated using Ki67, was lower in the intraductal carcinoma components than in the associated infiltrating carcinoma components (p < 0.001). The presence or absence of intraductal spread was not correlated with age, sex, tumor location, tumor size, or stage. IDAP with intraductal spread showed a tendency, although it was not significant (p = 0.092), to be associated with longer survival compared with IDAP without intraductal spread. Conclusion: IDAP, especially of the well-differentiated type, has a tendency to spread intraductally. The difference between the Ki67 labeling indexes in the intraductal and associated infiltrating carcinoma components suggests that these components show different biological behaviors. Copyright (C) 2002 S. Karger AG, Basel and IAP.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 25 条
[11]  
KOZUKA S, 1979, CANCER, V43, P1419, DOI 10.1002/1097-0142(197904)43:4<1418::AID-CNCR2820430431>3.0.CO
[12]  
2-O
[13]  
Kuwano H, 1998, INT J CANCER, V78, P149, DOI 10.1002/(SICI)1097-0215(19981005)78:2<149::AID-IJC4>3.0.CO
[14]  
2-Z
[15]  
Sobin LH, 1997, TNM CLASSIFICATION M
[16]  
SOLCIA E, 1997, ATLAS TUMOR PATHOL, P64
[17]   PANCREATIC DUCT HYPERPLASIA AND CANCER [J].
SOMMERS, SC ;
MURPHY, SA ;
WARREN, S .
GASTROENTEROLOGY, 1954, 27 (05) :629-640
[18]  
Suda K, 1991, Rinsho Byori, V39, P416
[19]  
SUDA K, 1976, ACTA PATHOL JAPON, V26, P561
[20]   K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers [J].
Sugio, K ;
Molberg, K ;
AlboresSaavedra, J ;
Virmani, AK ;
Kishimoto, Y ;
Gazdar, AF .
INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1997, 21 (03) :205-217